Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Toxins | 16 | 2026 | 273 | 3.750 |
Why?
|
| Bacterial Proteins | 10 | 2026 | 499 | 2.400 |
Why?
|
| Antigens, Bacterial | 6 | 2020 | 166 | 1.040 |
Why?
|
| Bacillus anthracis | 9 | 2020 | 154 | 1.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2018 | 26 | 1.010 |
Why?
|
| Macrophages | 8 | 2018 | 306 | 0.960 |
Why?
|
| Signal Transduction | 7 | 2026 | 1469 | 0.960 |
Why?
|
| Zinc Fingers | 4 | 2008 | 26 | 0.950 |
Why?
|
| Antibodies, Neutralizing | 4 | 2020 | 74 | 0.880 |
Why?
|
| Immunity, Innate | 3 | 2025 | 232 | 0.830 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2011 | 31 | 0.720 |
Why?
|
| Epitopes | 3 | 2020 | 185 | 0.680 |
Why?
|
| Leukocytes | 2 | 2018 | 72 | 0.660 |
Why?
|
| Anthrax | 4 | 2020 | 92 | 0.660 |
Why?
|
| Animals | 27 | 2025 | 10713 | 0.650 |
Why?
|
| Cyclic AMP | 3 | 2018 | 96 | 0.610 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 25 | 0.580 |
Why?
|
| Enterotoxins | 1 | 2017 | 22 | 0.550 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 6 | 0.550 |
Why?
|
| Peptide Fragments | 2 | 2017 | 202 | 0.530 |
Why?
|
| Repressor Proteins | 2 | 2019 | 119 | 0.510 |
Why?
|
| Sodium Selenite | 2 | 2008 | 4 | 0.490 |
Why?
|
| Cricetulus | 5 | 2020 | 56 | 0.460 |
Why?
|
| CHO Cells | 5 | 2020 | 96 | 0.460 |
Why?
|
| HeLa Cells | 3 | 2026 | 212 | 0.450 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 12 | 0.450 |
Why?
|
| Mice | 13 | 2023 | 4814 | 0.430 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 6 | 0.400 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 27 | 0.400 |
Why?
|
| Cell Line | 6 | 2018 | 701 | 0.400 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 634 | 0.380 |
Why?
|
| Humans | 22 | 2026 | 28995 | 0.380 |
Why?
|
| Cytokines | 6 | 2022 | 452 | 0.380 |
Why?
|
| Monocytes | 1 | 2013 | 135 | 0.370 |
Why?
|
| Receptors, Peptide | 2 | 2011 | 20 | 0.370 |
Why?
|
| Sp1 Transcription Factor | 3 | 2008 | 17 | 0.350 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 13 | 0.350 |
Why?
|
| Transcription Factor TFIIIA | 3 | 2008 | 12 | 0.330 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 54 | 0.330 |
Why?
|
| Dendritic Cells | 1 | 2011 | 144 | 0.310 |
Why?
|
| Hydrocarbons | 2 | 2010 | 41 | 0.310 |
Why?
|
| Transcription Factors | 3 | 2008 | 523 | 0.310 |
Why?
|
| Azoles | 1 | 2008 | 7 | 0.300 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 8 | 0.300 |
Why?
|
| Histidine | 2 | 2005 | 53 | 0.290 |
Why?
|
| Cysteine | 2 | 2005 | 68 | 0.290 |
Why?
|
| Clostridium Infections | 2 | 2020 | 67 | 0.280 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 79 | 0.280 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 103 | 0.280 |
Why?
|
| Cell Nucleus | 1 | 2008 | 138 | 0.270 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 697 | 0.270 |
Why?
|
| Spores, Bacterial | 3 | 2020 | 50 | 0.250 |
Why?
|
| Gold Sodium Thiomalate | 1 | 2005 | 3 | 0.240 |
Why?
|
| DNA | 2 | 2008 | 378 | 0.230 |
Why?
|
| Receptors, Steroid | 1 | 2025 | 26 | 0.220 |
Why?
|
| Antiviral Agents | 1 | 2025 | 114 | 0.210 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 1056 | 0.210 |
Why?
|
| Heart | 1 | 2005 | 232 | 0.210 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2024 | 158 | 0.210 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 7 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 82 | 0.190 |
Why?
|
| Liver | 2 | 2021 | 471 | 0.190 |
Why?
|
| Capillaries | 1 | 2021 | 33 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 22 | 0.170 |
Why?
|
| Anthrax Vaccines | 2 | 2020 | 35 | 0.170 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 44 | 0.170 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 69 | 0.170 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 114 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2023 | 668 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 68 | 0.170 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2000 | 14 | 0.170 |
Why?
|
| Carbon Monoxide | 1 | 2000 | 47 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 329 | 0.160 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1022 | 0.150 |
Why?
|
| Bacterial Vaccines | 1 | 2019 | 30 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2023 | 485 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2021 | 373 | 0.150 |
Why?
|
| Virulence Factors | 2 | 2017 | 45 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2018 | 20 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 286 | 0.140 |
Why?
|
| Amiloride | 1 | 2017 | 3 | 0.140 |
Why?
|
| Pinocytosis | 1 | 2017 | 17 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2009 | 585 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 169 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2008 | 72 | 0.130 |
Why?
|
| Xenopus laevis | 2 | 2008 | 50 | 0.120 |
Why?
|
| beta Catenin | 2 | 2022 | 66 | 0.120 |
Why?
|
| Sequence Alignment | 1 | 2015 | 112 | 0.110 |
Why?
|
| Virulence | 3 | 2009 | 154 | 0.110 |
Why?
|
| Rats | 4 | 2010 | 1592 | 0.100 |
Why?
|
| Protein Binding | 2 | 2013 | 667 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 278 | 0.100 |
Why?
|
| Immunoglobulin G | 3 | 2020 | 272 | 0.100 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 8 | 0.100 |
Why?
|
| Bucladesine | 1 | 2013 | 11 | 0.100 |
Why?
|
| Transcription Factor HES-1 | 1 | 2013 | 6 | 0.100 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 35 | 0.100 |
Why?
|
| Luciferases | 1 | 2013 | 54 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1351 | 0.100 |
Why?
|
| Peptidoglycan | 1 | 2013 | 47 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 124 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 79 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 53 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 202 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2009 | 515 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 157 | 0.090 |
Why?
|
| Female | 8 | 2021 | 15688 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 6 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 417 | 0.090 |
Why?
|
| Male | 7 | 2021 | 13983 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2011 | 65 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 490 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1660 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 92 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 150 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2023 | 266 | 0.080 |
Why?
|
| Molecular Weight | 2 | 2011 | 122 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 39 | 0.080 |
Why?
|
| Antigens, CD1d | 1 | 2009 | 45 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 84 | 0.080 |
Why?
|
| Neutralization Tests | 2 | 2020 | 34 | 0.070 |
Why?
|
| Isoindoles | 1 | 2008 | 5 | 0.070 |
Why?
|
| Natural Killer T-Cells | 1 | 2009 | 55 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 42 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 114 | 0.070 |
Why?
|
| Ovary | 1 | 2008 | 72 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 113 | 0.070 |
Why?
|
| Middle Aged | 5 | 2020 | 7428 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2008 | 43 | 0.070 |
Why?
|
| Chemokines | 2 | 2022 | 74 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 319 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 40 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 251 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 8048 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 404 | 0.060 |
Why?
|
| Circular Dichroism | 1 | 2005 | 43 | 0.060 |
Why?
|
| Xenopus | 1 | 2005 | 28 | 0.060 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2005 | 7 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 8 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 12 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 11 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 19 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2005 | 22 | 0.060 |
Why?
|
| Young Adult | 3 | 2020 | 2842 | 0.060 |
Why?
|
| Lead | 1 | 2005 | 10 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 45 | 0.060 |
Why?
|
| Cadmium | 1 | 2005 | 16 | 0.060 |
Why?
|
| Virus Replication | 1 | 2025 | 66 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 242 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 415 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 270 | 0.050 |
Why?
|
| Zinc | 1 | 2005 | 63 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 145 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 45 | 0.050 |
Why?
|
| Myocardium | 1 | 2005 | 197 | 0.050 |
Why?
|
| Thrombin | 1 | 2004 | 69 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 355 | 0.050 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 289 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 381 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.050 |
Why?
|
| Aged | 3 | 2021 | 5608 | 0.050 |
Why?
|
| Transcription Factor AP-2 | 1 | 2002 | 5 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2002 | 5 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2002 | 7 | 0.050 |
Why?
|
| Papio | 1 | 2023 | 81 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 28 | 0.050 |
Why?
|
| Calgranulin B | 1 | 2022 | 18 | 0.050 |
Why?
|
| Quinolones | 1 | 2022 | 22 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 284 | 0.050 |
Why?
|
| RNA | 1 | 2002 | 111 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 225 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 548 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 21 | 0.040 |
Why?
|
| Inflammation | 2 | 2021 | 668 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 119 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 70 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 2000 | 16 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 16 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2000 | 28 | 0.040 |
Why?
|
| Turkey | 1 | 2020 | 10 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 52 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2020 | 58 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2021 | 141 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 384 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 100 | 0.040 |
Why?
|
| Action Potentials | 1 | 2000 | 196 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 48 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2020 | 114 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 285 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2019 | 66 | 0.040 |
Why?
|
| Glycosylation | 1 | 2019 | 70 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 53 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 465 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 259 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 1619 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 687 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 336 | 0.040 |
Why?
|
| Brain | 1 | 2004 | 770 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 494 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 739 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2009 | 169 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 213 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 869 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2067 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 1019 | 0.030 |
Why?
|
| Chlorides | 1 | 2011 | 13 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2011 | 3 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 25 | 0.020 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 7 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 42 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 87 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 39 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2010 | 15 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 417 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2009 | 4 | 0.020 |
Why?
|
| Phosphopeptides | 1 | 2009 | 14 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 344 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2009 | 7 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 31 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 132 | 0.020 |
Why?
|
| Gene Order | 1 | 2008 | 10 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 34 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 39 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 554 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 82 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 292 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 199 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2008 | 110 | 0.020 |
Why?
|
| Complement C3c | 1 | 2008 | 3 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 20 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 10 | 0.020 |
Why?
|
| Trypsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Alanine Racemase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 30 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 45 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 419 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 480 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 300 | 0.010 |
Why?
|
| Nitroprusside | 1 | 2004 | 8 | 0.010 |
Why?
|
| Maleimides | 1 | 2004 | 6 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 74 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 257 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 113 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 109 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 111 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 251 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 198 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 780 | 0.010 |
Why?
|